X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (4) 4
humans (4) 4
breast-cancer (3) 3
female (3) 3
index medicus (3) 3
middle aged (3) 3
adult (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacokinetics (2) 2
antitumor-activity (2) 2
endothelial growth-factor (2) 2
factor receptor (2) 2
hand-foot syndrome - etiology (2) 2
indoles - adverse effects (2) 2
indoles - pharmacokinetics (2) 2
male (2) 2
pyrroles - adverse effects (2) 2
pyrroles - pharmacokinetics (2) 2
side effects (2) 2
sorafenib (2) 2
su11248 (2) 2
sunitinib (2) 2
sweat (2) 2
sweat - metabolism (2) 2
therapy (2) 2
toxicity (2) 2
tyrosine kinase inhibitor (2) 2
adherence (1) 1
adjuvant treatment (1) 1
administration, oral (1) 1
analgesics - therapeutic use (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - blood (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
biochemistry & molecular biology (1) 1
biomedicine (1) 1
biopsy (1) 1
biotransformation (1) 1
body fluids (1) 1
breast neoplasms - complications (1) 1
breast neoplasms - drug therapy (1) 1
calibration (1) 1
cancer (1) 1
carcinoma, renal cell - drug therapy (1) 1
carcinoma, renal cell - enzymology (1) 1
carcinoma, renal cell - secondary (1) 1
cell biology (1) 1
cell-carcinoma (1) 1
chemistry, analytical (1) 1
chemotherapy, adjuvant - adverse effects (1) 1
chemotherapy, adjuvant - methods (1) 1
chromatography, high pressure liquid - standards (1) 1
clones (1) 1
clonidine - therapeutic use (1) 1
comparative analysis (1) 1
ctla-4 antigen - antagonists & inhibitors (1) 1
ctla-4 antigen - immunology (1) 1
ctla-4 protein (1) 1
cyclohexanols - therapeutic use (1) 1
dealkylation (1) 1
disease (1) 1
disease-free survival (1) 1
dosage and administration (1) 1
double-blind method (1) 1
doxorubicin (1) 1
drug abuse (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
excretion (1) 1
feasibility (1) 1
feasibility studies (1) 1
foot skin reaction (1) 1
gabapentin (1) 1
hand-foot syndrome - metabolism (1) 1
high-performance liquid chromatography (1) 1
hot flashes - chemically induced (1) 1
hot flashes - drug therapy (1) 1
hot flashes - etiology (1) 1
immune checkpoint (1) 1
immunotherapy (1) 1
impact (1) 1
indoles - administration & dosage (1) 1
indoles - blood (1) 1
ipilimumab (1) 1
ipilimumab - administration & dosage (1) 1
ipilimumab - adverse effects (1) 1
kidney neoplasms - drug therapy (1) 1
kidney neoplasms - enzymology (1) 1
kidney neoplasms - pathology (1) 1
limit of detection (1) 1
lymphocytes (1) 1
lymphocytes t (1) 1
mass spectroscopy (1) 1
medicine, research & experimental (1) 1
melanoma (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 11/2018, Volume 24, Issue 11, pp. 1655 - 1661
Journal Article
Journal of Analytical Toxicology, ISSN 0146-4760, 10/2011, Volume 35, Issue 8, pp. 558 - 565
Journal Article
Journal of Analytical Toxicology, ISSN 0146-4760, 10/2011, Volume 35, Issue 8, pp. 558 - 565
Skin reactions are side effects of sunitinib therapy with an adverse impact on quality of life often necessitating dose reductions. For conventional... 
Drug abuse | Excretion | Side effects | Metabolites | Secretion | Toxicity | Mass spectroscopy | Skin | High-performance liquid chromatography | Doxorubicin | Sweat | Quality of life
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.